David Gunn

1.3k total citations
25 papers, 939 citations indexed

About

David Gunn is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, David Gunn has authored 25 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in David Gunn's work include Nicotinic Acetylcholine Receptors Study (8 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Gastrointestinal motility and disorders (5 papers). David Gunn is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (8 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Gastrointestinal motility and disorders (5 papers). David Gunn collaborates with scholars based in United States, United Kingdom and Mexico. David Gunn's co-authors include Martin H. Osterhout, Albert Padwa, Nan‐Horng Lin, Stephen P. Arnerić, Mark W. Holladay, James P. Sullivan, Peter Mansell, Diana L. Donnelly‐Roberts, David S. Garvey and Michael L. Jones and has published in prestigious journals such as American Journal of Clinical Nutrition, Gut and Journal of Medicinal Chemistry.

In The Last Decade

David Gunn

25 papers receiving 903 citations

Peers

Countries citing papers authored by David Gunn

Since Specialization

Citations

This map shows the geographic impact of David Gunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gunn more than expected).

Fields of papers citing papers by David Gunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gunn. The network helps show where David Gunn may publish in the future.

Co-authorship network of co-authors of David Gunn

This figure shows the co-authorship network connecting the top 25 collaborators of David Gunn. A scholar is included among the top collaborators of David Gunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gunn. David Gunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms underlying the laxative effect of lactulose: A randomized placebo‐controlled trial showing increased small bowel water and motility unaltered by the 5‐HT₃ receptor antagonist, ondansetron 2024 ·Neurogastroenterology & Motility ·David Gunn, (unknown), Caroline L. Hoad, Alex Menys, Penny Gowland, Luca Marciani, Robert E. Spiller	2
2	Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery 2022 ·Gut ·Jonna Jalanka, David Gunn, Gulzar Singh, (unknown), Melanie Lingaya, Fiona Crispie, Laura Finnegan, Paul D. Cotter, Louise James, (unknown), Giles Major, Robert E. Spiller	20
3	Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies 2021 ·Gut ·David Gunn, Zainab Sabri Abbas, Hannah C. Harris, Giles Major, Caroline L. Hoad, Penny Gowland, Luca Marciani, Samantha Gill, Frederick J. Warren, Megan Rossi, J.M. Remes-Troche, Kevin Whelan, Robert E. Spiller	31
4	Test–retest assessment of non-contrast MRI sequences to characterise and quantify the small bowel wall in healthy participants 2021 ·Magnetic Resonance Materials in Physics Biology and Medicine ·(unknown), Hannah Williams, Konstantinos Argyriou, David Gunn, Victoria Wilkinson‐Smith, Jonathan White, Jaber Alyami, Penny Gowland, Gordon W. Moran, Caroline L. Hoad	4
5	Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial 2020 ·American Journal of Clinical Nutrition ·David Gunn, (unknown), Giles Major, Victoria Wilkinson‐Smith, Caroline L. Hoad, Luca Marciani, J.M. Remes-Troche, Samantha Gill, Megan Rossi, Hannah C. Harris, Jennifer Ahn‐Jarvis, Frederick J. Warren, Kevin Whelan, Robert E. Spiller	15
6	Abnormalities of mucosal serotonin metabolism and 5‐HT₃ receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron 2019 ·Alimentary Pharmacology & Therapeutics ·David Gunn, Klara Garsed, Ching Lam, Gulzar Singh, Melanie Lingaya, (unknown), Beate Niesler, Amanda P. Henry, Ian P. Hall, Peter J. Whorwell, Robert E. Spiller	28
7	Chronic diarrhoea in adults 2019 ·Current Opinion in Gastroenterology ·Giles Major, David Gunn	2
8	An analysis of the cost and clinical effectiveness of the laboratory tests for Ironstudies including deficiency (Anaemia) and overload (Haemochromatosis): Thedistrict general perspective. 2017 ·Tariq Mahmood, David Gunn, (unknown)	1
9	Glycaemic control and weight 7 years after Dose Adjustment For Normal Eating (DAFNE) structured education in Type 1 diabetes 2011 ·Diabetic Medicine ·David Gunn, Peter Mansell	48
10	Prospects for Kinase Activity Modulators in the Treatment of Diabetes and Diabetic Complications 2002 ·Current Topics in Medicinal Chemistry ·William H. Bullock, Steven Magnuson, (unknown), David Gunn, Joachim Rudolph	18
11	Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic Acids as Leukotriene Biosynthesis Inhibitors 2000 ·Journal of Medicinal Chemistry ·Teodozyj Kolasa, David Gunn, Pramila Bhatia, Keith W. Woods, (unknown), Andrew O. Stewart, Jennifer B. Bouska, Richard R. Harris, Keren I. Hulkower, (unknown), Randy L. Bell, George W. Carter, Clint D. W. Brooks	28
12	Symmetrical Bis(heteroarylmethoxyphenyl)alkylcarboxylic Acids as Inhibitors of Leukotriene Biosynthesis 2000 ·Journal of Medicinal Chemistry ·Teodozyj Kolasa, David Gunn, Pramila Bhatia, Anwer Basha, (unknown), Andrew O. Stewart, Jennifer B. Bouska, Richard R. Harris, Keren I. Hulkower, (unknown), Randy L. Bell, George W. Carter, Clint D. W. Brooks	25
13	Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin, (unknown), David Gunn, Suzanne A. Lebold, Edmund Lee, James T. Wasicak, (unknown), Jerome F. Daanen, David S. Garvey, Jeffrey E. Campbell, (unknown), Michael T. Williams, Stephen P. Arnerić	12
14	Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist 1998 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin, David Gunn, Yihong Li, Yun He, (unknown), Keith B. Ryther, Theresa A. Kuntzweiler, Diana L. Donnelly‐Roberts, David J. Anderson, Jeffrey E. Campbell, James P. Sullivan, Stephen P. Arnerić, Mark W. Holladay	35
15	Design of inhibitors of leukotriene biosynthesis and their therapeutic potential 1998 ·Pure and Applied Chemistry ·Clint D. W. Brooks, Andrew O. Stewart, Teodozyj Kolasa, A. BASHA, Pramila Bhatia, James D. Ratajczyk, (unknown), David Gunn, Richard R. Harris, Jennifer B. Bouska, (unknown), Randy L. Bell, (unknown)	5
16	ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties 1997 ·Journal of Pharmacology and Experimental Therapeutics ·James P. Sullivan, Diana L. Donnelly‐Roberts, (unknown), David J. Anderson, Murali Gopalakrishnan, (unknown), Marietta Piattoni-Kaplan, Eduardo Molinari, Jeffrey E. Campbell, David G. McKenna, David Gunn, Nan‐Horng Lin, Keith B. Ryther, Yun He, Mark W. Holladay, Susan Wonnacott, Michael T. Williams, Stephen P. Arnerić	70
17	Application of the Pummerer Reaction Toward the Synthesis of Complex Carbocycles and Heterocycles 1997 ·Synthesis ·Albert Padwa, David Gunn, Martin H. Osterhout	114
18	Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties 1997 ·Journal of Medicinal Chemistry ·Nan‐Horng Lin, David Gunn, Keith B. Ryther, David S. Garvey, Diana L. Donnelly‐Roberts, Michael Decker, Jorge D. Brioni, Michael Buckley, A. David Rodrigues, Kennan Marsh, David J. Anderson, Jerry J. Buccafusco, Mark Prendergast, James P. Sullivan, Michael Williams, Stephen P. Arnerić, Mark W. Holladay	44
19	ChemInform Abstract: Novel 3‐Pyridyl Ethers with Subnanomolar Affinity for Central Neuronal Nicotinic Acetylcholine Receptors (nAChR′s). 1996 ·ChemInform ·(unknown), (unknown), David S. Garvey, David Gunn, (unknown), James T. Wasicak, (unknown), Yvonne C. Martin, Diana L. Donnelly‐Roberts, David J. Anderson, James P. Sullivan, Michael T. Williams, Stephen P. Arnerić, Mark W. Holladay	8
20	Synthesis and resolution of 2-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid, leukotriene biosynthesis inhibitors 1996 ·Tetrahedron Asymmetry ·Teodozyj Kolasa, David Gunn, Andrew O. Stewart, Clint D. W. Brooks	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact